Sezer AKÇER, Oğuz Aslan ÖZEN, Bumin DEĞİRMENCİ, Ozan TURAMANLAR, Ramazan UYGUR, Oğuz KIRPIKO

Absence of middle hepatic vein combined with retro-aortic left renal vein: A very rare case report

Hepatik ve renal venler v. cava inferior’a açılırlar. Üst gruptaki hepatik venler üç venden meydana gelir ve bunlar karaciğerin arka yüzüne doğru uzanarak v. cava inferior’a açılırlar. V. renalis sinistra, a. mesenterica superior’un başlangıç kısmının hemen aşağısında aorta’nın ön tarafından geçer. Biz Afyon Kocatepe Üniversitesi Tıp Fakültesi Radyoloji Anabilim Dalı’nda 9 yaşında erkek hastanın multislice BT anjiografisinde hepatik ve renal venlerinde varyasyon saptadık. Normalde üst grup hepatik venler sağ, sol ve orta olarak adlandırılan üç ayrı gövde şeklinde v. cava inferior’a açılırlar. Olgumuzda sadece sağ ve sol hepatik venlerin var olduğunu, orta hepatik venin olmadığını bulduk. Ayrıca, normalde aorta abdominalis’in ön tarafından geçmesi gereken v. renalis sinistra, retroaortik idi. V. renalis sinistra varyasyonları retroperitoneal cerrahi ve vasküler girişimlerin planlanmasında büyük öneme sahiptir. Hepatik ven ve böbrek damar anatomisinin bilinmesi ve bu damarların varyasyonlarının ve anomalilerinin tespit edilmesi, abdominal operasyonlar, organ nakilleri ve endovasküler girişimlerin preoperatif değerlendirmelerinde kritik öneme sahiptir.

Orta hepatik venin olmaması ile birlikte retroaortik renal ven: Çok nadir bir olgu sunumu

The hepatic and renal veins drain into the inferior vena cava. The upper group of hepatic veins consists of three veins which extend to the posterior face of the liver to join the inferior cava. The left renal vein passes anterior to the aorta just below the origin of the superior mesenteric artery. We detected a variation in the hepatic and renal veins in a multislice CT angiogram of a nine-year-old male patient in the Radiology Department of Afyon Kocatepe University Medical School. The upper group hepatic veins normally drains into the inferior vena cava as three separate trunks, namely the right, left and middle. In our case, we found that only the right and left hepatic veins existed and the middle hepatic vein was absent. Furthermore, the left renal vein, which normally passes anterior to the abdominal aorta, was retro-aortic. Left renal vein variations are of great importance in planning retroperitoneal surgery and vascular interventions. Knowledge of a patient's hepatic vein and renovascular anatomy and determining their variations and anomalies are of critical importance to abdominal operations, transplantations and preoperative evaluation of endovascular interventions.

PDF

___

1. Dienstag JL, Hepatitis B. virus infection. N Engl J Med 2008;359:1486-500. [CrossRef]
2. Reynaud L, Carleo MA, Talamo M, Borgia G. Tenofovir and its potential in the treatment of hepatitis B virus. Ther Clin Risk Manag 2009;5:177-85.
3. Alter MJ. Epidemiology of hepatitis B in Europe and worldwide. J Hepatol 2003;39:64-9. [CrossRef]
4. Tan HH, Lui HF, Chow WC. Chronic hepatitis B virus (HBV) infection in pregnancy. Hepatol Int 2008;2:370-5. [CrossRef]
5. Jonas MM. Hepatitis B and pregnancy: an underestimated issue. Liver Int 2009;291:133-9. [CrossRef]
6. Peters MG. Special populations with hepatitis B virus infection. Hepatology 2009;49:S146-55. [CrossRef]
7. Elefsiniotis I, Tsoumakas K, Vezali E, Glynou I, Drakoulis N, Saroglou G. Spontaneous preterm birth in women with chronic hepatitis B virus infection. Int J Gynecol Obstet 2010.
8. Tran TT. Management of hepatitis B in pregnancy: weighing the options. Cleve Clin J Med 2009;76:S25-9. [CrossRef]
9. Antiretroviral Pregnancy Registry: Available at http://www.apregistry. com.Accessed August 2010.
10. van Bommel F, Wunsche T, Mauss S, Reinke P, Bergk A, Schürmann D, et al. Comparison of adefovir and tenofovir in the treatment of lamivudine-resistant hepatitis B virus infection. Hepatology 2004;40:1421-5. [CrossRef]
11. van Bommel F, Zollner B, Sarrazin C, Spengler U, Huppe D, Möller B, et al. Tenofovir for patients with lamivudine-resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapy. Hepatology 2006;44:318-25. [CrossRef]
12. Sargent IL. Maternal and fetal immune responses during pregnancy. Exp Clin Immunogenet 1993;10:85-102.
13. Gervais A, Bacq Y, Bernuau J, Martinot M, Auperin A, Boyer N, et al. Decrease in serum ALT and increase in serum HCV RNA during pregnancy in women with chronic hepatitis C. J Hepatol 2000;32:293-9. [CrossRef]
14. Xu DZ, Yan YP, Choi BC, Xu JQ, Men K, Zhang JX, et al. Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case- control study. J Med Virol 2002;67:20-6. [CrossRef]
15. Bzowej NH. Hepatitis B therapy in pregnancy. Curr Hepatitis Rep 2010;9:197-204. [CrossRef]
16. Romero R, Espinoza J, Kusanovic JP, Gotsch F, Hassan S, Erez O, et al. The preterm parturition syndrome. BJOG 2006;113:17-42. [CrossRef]
17. Wong S, Chan LY, Yu V, Ho L. Hepatitis B carrier and perinatal outcome in singleton pregnancy. Am J Perinatol 1999;16:485-8. [CrossRef]